Ⅱ型前膠原羧基端原肽(PIICP)檢測試劑盒(酶聯(lián)免疫吸附試驗法)
ELISA Kit for Procollagen II C-Terminal Propeptide (PIICP)
P2CP; C-Propeptide Of Type II Procollagen; Procollagen II Carboxy Terminal Propeptide
- 編號CEA964Hu
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 實驗方法競爭抑制
- 反應(yīng)時長2h
- 檢測范圍2.47-200ng/mL
- 靈敏度最小可檢測劑量小于等于0.93ng/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價格 ¥ 2646 ¥ 3780 ¥ 17010 ¥ 32130 ¥ 264600
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測Ⅱ型前膠原羧基端原肽(PIICP),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的Ⅱ型前膠原羧基端原肽(PIICP)(加標(biāo)樣品),重復(fù)測定并計算其均值,回收率為測定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 78-94 | 89 |
EDTA plasma(n=5) | 87-94 | 90 |
heparin plasma(n=5) | 80-97 | 84 |
精密度
精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定,每個樣本使用同一試劑盒重復(fù)測定8次,分別計算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的Ⅱ型前膠原羧基端原肽(PIICP),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中Ⅱ型前膠原羧基端原肽(PIICP)含量的測定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 91-105% | 91-105% | 91-101% | 88-102% |
EDTA plasma(n=5) | 88-101% | 91-99% | 98-105% | 87-99% |
heparin plasma(n=5) | 87-94% | 96-105% | 80-104% | 79-101% |
穩(wěn)定性
經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內(nèi)溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。
實驗流程
1. 實驗前標(biāo)準品、試劑及樣本的準備;
2. 加樣(標(biāo)準品及樣本)50µL,
加入50µL檢測液A(臨用前配制);
37°C溫育1小時。
3. 洗板3次;
4. 加檢測溶液B100µL,37°C孵育30分鐘;
5. 洗板5次;
6. 加TMB底物90µL,37°C孵育10-20分鐘;
7. 加終止液50µL,立即450nm讀數(shù)。
實驗原理
本試劑盒應(yīng)用競爭抑制酶聯(lián)免疫分析法測定標(biāo)本中待測物質(zhì)水平。將Ⅱ型前膠原羧基端原肽(PIICP)單克隆抗體包被微孔板,制成固相載體,往包被抗體的微孔中同時加入生物素標(biāo)記的抗原和待測抗原(標(biāo)準品或樣本),待測抗原與生物素標(biāo)記抗原對特異性抗體進行競爭結(jié)合。溫育后經(jīng)洗滌去掉未結(jié)合物,然后加入HRP標(biāo)記的親和素,經(jīng)過溫育和徹底洗滌后加入底物TMB顯色。TMB在過氧化物酶的催化下轉(zhuǎn)化成藍色,并在酸的作用下轉(zhuǎn)化成最終的黃色。待測標(biāo)本濃度越高,標(biāo)記抗原和抗體的結(jié)合就越受到抑制,顯色愈淺。顯色的深淺與酶量呈正相關(guān),而與樣品中待測物質(zhì)含量呈負相關(guān)。用酶標(biāo)儀在450nm波長下測定吸光度(O.D.值),計算樣品濃度。
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA964Hu01 | Ⅱ型前膠原羧基端原肽(PIICP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA964Hu02 | Ⅱ型前膠原羧基端原肽(PIICP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA964Hu21 | Ⅱ型前膠原羧基端原肽(PIICP)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAA964Hu08 | Ⅱ型前膠原羧基端原肽(PIICP)多克隆抗體 | WB; IHC; ICC; IP. |
PAA964Hu01 | Ⅱ型前膠原羧基端原肽(PIICP)多克隆抗體 | WB; IHC; ICC; IP. |
PAA964Hu02 | Ⅱ型前膠原羧基端原肽(PIICP)多克隆抗體 | WB; IHC; ICC; IP. |
SEA964Hu | Ⅱ型前膠原羧基端原肽(PIICP)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
CEA964Hu | Ⅱ型前膠原羧基端原肽(PIICP)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA964Hu | Ⅱ型前膠原羧基端原肽(PIICP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA964Hu11 | Ⅱ型前膠原羧基端原肽(PIICP)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Experimental and Therapeutic Medicine | Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: A … [10.3892] |
Functional Foods in Health & Disease | Evaluation of the effect of administering N-acetyl-glucosamine-containing green tea supplement on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: a randomized double-blind placebo-controlled clinical study [309] |
EXPERIMENTAL AND THERAPEUTIC MEDICINE | Effect of N-acetylglucosamine administration on cartilage metabolism and safety in healthy subjects without symptoms of arthritis: A case report [pubmed:28413518] |
Experimental?and?Therapeutic?Medicine | Evaluation of the effect of salmon nasal proteoglycan on biomarkers for cartilage metabolism in individuals with knee joint discomfort: A randomized double?blind placebo?controlled clinical study [etm:14] |
Experimental and Therapeutic Medicine | Evaluation of the efficacy of Ajuga decumbens extract supplement in individuals with knee discomfort associated with physical activity: A randomized, double?blind, placebo?controlled study [10.3892/etm.2017.5064] |
EXPERIMENTAL AND THERAPEUTIC MEDICINE | Evaluation of the chondroprotective action of N?acetylglucosamine in a rat experimental osteoarthritis [pubmed:28912864] |
Functional Foods In Health And Disease | Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals: a randomized double-blind placebo-controlled clinical study [view/366] |
Spine | No effects of hyperosmolar culture medium on tissue regeneration by human degenerated nucleus pulposus cells despite upregulation extracellular matrix genes [fulltext:2018/03010] |
Advances in?Clinical?and Experimental?Medicine | Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with?… [68362.pdf] |
Functional Food Research | サケ鼻軟骨由來プロテオグリカン摂取による関節(jié)保護効果 [] |
Spine | No Effects of Hyperosmolar Culture Medium on Tissue Regeneration by Human Degenerated [Pubmed: 25856264] |
Applied Physiology Nutrition and Metabolism | Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain; A randomized controlled trial [Pubmed: 31990581] |
International Journal of Molecular Sciences | Bone Morphogenetic Proteins for Nucleus Pulposus Regeneration [Pubmed: 32295299] |
Biomolecules | Concerted Actions by PIICP, CTXII, and TNF-|á in Patients with Juvenile Idiopathic Arthritis [33924892] |